fbpx
Sign up now!
Don't show this again

Thank you for confirming your subscription!

(And remember, if ever you want to change your email preferences or unsubscribe, just click on the links at the bottom of any email.)

We’re glad you’re enjoying Poultry Health Today.
Access is free but you’ll need to register to view more content.
Already registered? Sign In
Tap to download the app
X
Share
X

REPORTS

Collect articles and features into your own report to read later, print or share with others

Create a New Report

Favorites

Read Later

Create a new report

Report title (required) Brief description (optional)
CREATE
X
NEXT
POULTRY PORK FISH
follow us


You must be logged in to edit your profile.

Favorites Read Later My Reports PHT Special Reports
Poultry Health Today is equipped with some amazing (and free) tools for organizing and sharing content, as well as creating your own magazines and special reports. To access them, please register today.
Sponsored by Zoetis

Sponsored By Zoetis

.
Featured Video Play Icon

Cross-protection vaccine protocols key to limiting DMV/1639 spread in US flocks

Thorough vaccination programs and bird surveillance are critical to giving US flocks the best possible chance of protection against evolving strains of infectious bronchitis virus (IBV).

Brian Jordan, PhD, associate professor at the University of Georgia, said that while vaccinating against IBV is standard procedure in the poultry industry, matching a vaccine to the strain of the virus isn’t always possible.

This is because the virus often makes mistakes when it replicates, resulting in changes to its genetic makeup and the creation of new variants like DMV/1639 — a strain that has become one of the most common forms of IBV in US poultry production.

To address the challenge, producers combine different serotype vaccines to achieve cross-protection — a move that has gained traction in the US in recent years. However, not all combinations work equally well, Jordan told Poultry Health Today.

In a bid to measure the effectiveness of cross-protection programs against DMV/1639, Jordan and his team investigated the efficacy of Massachusetts and Georgia/08-type vaccination programs in flocks.

“We were…trying to understand why or how that challenge virus continues to move around the US [and] continues to be detected and isolated from different operations, even when that vaccine program is in use,” he said.

“And ultimately what we wanted to try to understand was how…these vaccines may prevent clinical signs [and] reduce some of the viral load in the field, but they don’t completely stop the virus,” he added. “How is that going to include the evolution of our next variant virus?”

In the study, Jordan and his team attempted to mimic what happens in the field by only vaccinating some birds and mixing groups of birds together to represent fully-vaccinated flocks, completely unvaccinated flocks and flocks where vaccination wasn’t perfect.

By looking at how DMV/1639 moved between the populations, the team wanted to know if thorough vaccination, which allowed birds to develop an immune response, would be enough to stop the virus from transmitting to other birds and spreading around the country.

The trial results showed the virus spread quickly between non-vaccinated birds, as well as between vaccinated birds that had been challenged and non-vaccinated birds.

However, what was more interesting, Jordan said, was that the team saw challenge-virus transmission in birds that were vaccinated and challenged, to other birds that were also well-vaccinated.

“[This] tells us that even in this Mass-Georgia/08 vaccination program, which I think is being pretty universally used for cross-protection…we do still have infection and replication of that challenge virus in the background,” he said.

“There was a significant reduction in clinical signs. You couldn’t tell that these birds were challenged. They looked perfectly healthy, and there would have been no issues at a processing plant, but we are still having virus infection and replication, which ultimately may influence how this virus changes or mutates in the future if it continues to do that.”

For Jordan, the findings demonstrate the importance of efficient vaccination application programs, ensuring all birds are vaccinated and able to mount an effective immune response.

“Management always plays a role in these viruses as well,” he added. “Viruses do better in cold weather, which correlates to a time when our management tends to suffer in the house because we don’t want to bring cold air in [and houses can get stuffy].

“So maybe focusing on vaccination, [and] making our management, particularly in the winter and spring, as good as it can possibly be [are what’s most important].

“And then just doing surveillance in your flocks to understand what viruses you actually have and tailoring the vaccine program to those particular challenges.”

 

 

 

Share It
Combining serotype vaccines might be a popular approach to protecting flocks against evolving strains of infectious bronchitis virus, such as DMV/1639, but not all combinations work equally well.

Click an icon to share this information with your industry contacts.



Posted on May 4, 2021

tags: , , ,
RELATED NEWS



You must be logged in to edit your profile.

Share It
Genotypes of infectious bronchitis virus (IBV) found in California between 2012 and 2020 have seen a “major shift,” according to a study investigating patterns of IBV in the state.

Click an icon to share this information with your industry contacts.
Google Translate is provided on this website as a reference tool. However, Poultry Health Today and its sponsor and affiliates do not guarantee in any way the accuracy of the translated content and are not responsible for any event resulting from the use of the translation provided by Google. By choosing a language other than English from the Google Translate menu, the user agrees to withhold all liability and/or damage that may occur to the user by depending on or using the translation by Google.